Abstract
Background: Patients with rheumatic diseases are more likely to suffer from anxiety, depression and insomnia. Yet, little is known about mental health status during COVID-19 pandemic.
Objective: This study aims to measure the prevalence of mental health disorders among patients with rheumatic diseases in the era of COVID-19 pandemic and to determine potential risk factors for major symptoms of depression, anxiety, and insomnia in participants.
Methods: Participants with rheumatic diseases were asked to complete a questionnaire using a telephonic interview. Sociodemographic and rheumatic disease characteristics were recorded. Mental health status was assessed by the patient health questionnaire-9 (PHQ-9), generalized anxiety disorder (GAD)-7, and insomnia severity index (ISI) questionnaires to detect depression, anxiety and insomnia symptoms, respectively.
Results: We included 307 patients in the survey. Rheumatoid arthritis was the most frequent diagnosis (55%). Of all participants, 7.5% had known depression and 5.5% known anxiety. Mental health disorders were insomnia (34.9%), anxiety (33.2%), and depression (24.4%). Major symptoms of insomnia, anxiety, and depression were noted in respectively, 19.9%, 12.4%, and 7.8% of participants. Risk factors for major insomnia were male gender (OR= 4.36, 95% CI 2.06 to 9.25; p<0.0001), low socioeconomic status (OR= 2.64, 95% CI 1.44 - 4.83; p<0.002) and having rheumatoid arthritis (OR= 2.00, 95% CI 1.04 to 3.84; p<0.036). Major anxiety was associated with low monthly income (OR=1.79, 95% CI 1.07 to 3.01; p<0.026), and higher Numerical Rating Scale (NRS) of pain (OR=1.795, 95% CI 1.074 to 2.994 ; p<0.026). Major depression was associated with the worsening of rheumatic disease (OR=1.86, 95% CI 1.06 to 3.26; p<0.03).
Conclusion: A high frequency of undiagnosed depression, anxiety and insomnia symptoms was found in rheumatic patients. Rheumatologists should be aware of these comorbidities, especially in the era of COVID-19 pandemic.
Keywords: Mental health, anxiety, depression, insomnia, rheumatic diseases, COVID-19.
[http://dx.doi.org/10.1007/s10067-014-2677-0] [PMID: 24859781]
[http://dx.doi.org/10.1177/0961203314540762] [PMID: 24944187]
[http://dx.doi.org/10.1007/s10865-012-9447-8] [PMID: 22864597]
[http://dx.doi.org/10.1093/rheumatology/ket169] [PMID: 24003249]
[http://dx.doi.org/10.3899/jrheum.180868] [PMID: 30770507]
[http://dx.doi.org/10.1186/s13075-018-1644-6] [PMID: 29996916]
[http://dx.doi.org/10.2217/ijr.11.62] [PMID: 22211138]
[PMID: 15184703]
[http://dx.doi.org/10.1093/rheumatology/keq327] [PMID: 21059675]
[http://dx.doi.org/10.1093/rheumatology/kep170] [PMID: 19608723]
[http://dx.doi.org/10.1093/rheumatology/kes356] [PMID: 23236191]
[http://dx.doi.org/10.1001/archinte.160.14.2101] [PMID: 10904452]
[http://dx.doi.org/10.1016/S0140-6736(09)60879-5] [PMID: 19640579]
[http://dx.doi.org/10.1016/j.genhosppsych.2010.12.001] [PMID: 21596201]
[http://dx.doi.org/10.1111/1756-185X.12412] [PMID: 25291016]
[http://dx.doi.org/10.1093/rheumatology/kev306] [PMID: 26350486]
[http://dx.doi.org/10.1177/0020764020915212] [PMID: 32233719]
[PMID: 16206362]
[http://dx.doi.org/10.1097/BOR.0000000000000387] [PMID: 28376060]
[http://dx.doi.org/10.1002/acr.21649] [PMID: 22473918]
[PMID: 18412311]
[http://dx.doi.org/10.1186/s12991-017-0155-1]
[http://dx.doi.org/10.1046/j.1525-1497.2001.016009606.x] [PMID: 11556941]
[http://dx.doi.org/10.1186/s12891-016-1011-1] [PMID: 27068100]
[http://dx.doi.org/10.1016/j.psychres.2016.03.030] [PMID: 27031595]
[http://dx.doi.org/10.1001/archinte.166.10.1092] [PMID: 16717171]
[http://dx.doi.org/10.1111/j.1547-5069.2010.01374.x] [PMID: 21342424]
[http://dx.doi.org/10.1016/S1389-9457(00)00065-4] [PMID: 11438246]
[http://dx.doi.org/10.24875/RIC.18002698] [PMID: 31056610]
[http://dx.doi.org/10.1056/NEJMoa2001316] [PMID: 31995857]
[http://dx.doi.org/10.1056/NEJMc2001468] [PMID: 32003551]
[http://dx.doi.org/10.1002/jmv.25689] [PMID: 31994742]
[http://dx.doi.org/10.1016/j.bbi.2020.04.028] [PMID: 32298802]
[http://dx.doi.org/10.1177/070674370905400504] [PMID: 19497162]
[http://dx.doi.org/10.1002/acr2.11148] [PMID: 32311836]
[http://dx.doi.org/10.1136/bmj.m516] [PMID: 32033967]
[http://dx.doi.org/10.3201/eid1212.060584] [PMID: 17326946]
[http://dx.doi.org/10.1159/000077743] [PMID: 15184719]
[http://dx.doi.org/10.1017/S0033291700025526] [PMID: 8234581]
[http://dx.doi.org/10.1001/jama.280.2.147] [PMID: 9669787]
[http://dx.doi.org/10.1016/S0304-3959(00)00483-8] [PMID: 11323140]
[http://dx.doi.org/10.1016/S2215-0366(18)30255-4] [PMID: 30366684]
[http://dx.doi.org/10.1006/cyto.1997.0238] [PMID: 9367546]
[http://dx.doi.org/10.1038/mp.2016.3] [PMID: 26903267]
[http://dx.doi.org/10.1111/acps.12698] [PMID: 28122130]
[http://dx.doi.org/10.1016/j.bbi.2015.06.001] [PMID: 26065825]
[http://dx.doi.org/10.1136/jnnp.74.11.1587] [PMID: 14617727]
[PMID: 16960928]
[http://dx.doi.org/10.1371/journal.pone.0230273] [PMID: 32197267]